Human Vaccines & Immunotherapeutics Journal Citation Rate 2026
2164-5515
eISSN 2164-554X
Taylor & Francis
US
Q1 Quartile Open Access Established Impact
About Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics (HVI) is a peer-reviewed academic journal covering Hepatitis B Virus Studies and Influenza Virus Research Studies, published by Taylor & Francis in US, catalogued under ISSN 2164-5515 (e-ISSN 2164-554X). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 3.63 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $3175 USD.
Human Vaccines & Immunotherapeutics Citation Rate 2026 — In Context
Human Vaccines & Immunotherapeutics has a 2025 2-Year Citation Rate (OpenAlex) of 3.63, placing it in the Q1 quartile within the Hepatitis B Virus Studies research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, Human Vaccines & Immunotherapeutics makes all articles freely available to readers for an Article Processing Charge of approximately $3175 USD.
Researchers looking to publish in Human Vaccines & Immunotherapeutics should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Human Vaccines & Immunotherapeutics against similar journals in the field, use our journal comparison tool.
Submission Tips for Human Vaccines & Immunotherapeutics
- Budget $3175 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Hepatitis B Virus Studies, Influenza Virus Research Studies, Respiratory viral infections research. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Human Vaccines & … Compares
Compared against 13 journals in the same research areas.
| ISSN (Print) | 2164-5515 |
|---|---|
| ISSN (Online) | 2164-554X |
| Publisher | Taylor & Francis |
| Country | United States |
| APC / Cost | $3175 USD |
In-depth profile & metrics
Human Vaccines & Immunotherapeutics is published by Taylor & Francis and based in United States. It publishes open access with an article-processing charge of USD 3175.
In our subject taxonomy, Human Vaccines & Immunotherapeutics is classified under Hepatitis B Virus Studies, Influenza Virus Research Studies, Respiratory viral infections research and SARS-CoV-2 and COVID-19 Research.
Human Vaccines & Immunotherapeutics is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 3.627.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Human Vaccines & Immunotherapeutics
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 3.627 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Human Vaccines & Immunotherap… against similar publications in its field:
Related Journals in Your Field
-
EBioMedicine Elsevier BV IF 8.28
-
BMJ Medicine BMJ IF 6.02
-
European Journal of Epidemiology Springer Science+Business Media IF 4.90
-
Liver International Wiley IF 3.95
-
Virology Journal BioMed Central IF 3.46
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S2483136528
Get weekly updates for Hepatitis B Virus Studies journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.